GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Short-Term Debt

Aarti Drugs (BOM:524348) Short-Term Debt : ₹2,871 Mil (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Short-Term Debt?

Aarti Drugs's Short-Term Debt for the quarter that ended in Mar. 2024 was ₹2,871 Mil.

Aarti Drugs's quarterly Short-Term Debt declined from Sep. 2023 (₹3,751 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹2,871 Mil).

Aarti Drugs's annual Short-Term Debt increased from Mar. 2022 (₹3,998 Mil) to Mar. 2023 (₹4,018 Mil) but then declined from Mar. 2023 (₹4,018 Mil) to Mar. 2024 (₹2,871 Mil).


Aarti Drugs Short-Term Debt Historical Data

The historical data trend for Aarti Drugs's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Short-Term Debt Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,990.36 1,968.22 3,998.40 4,018.42 2,870.90

Aarti Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,018.42 - 3,750.70 - 2,870.90

Aarti Drugs Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Aarti Drugs Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines